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Abstract 1 
 2 
Deficits in visual short-term memory (VSTM) binding have been proposed as an early and 3 
specific marker for AlzheimerÕs disease (AD). However, no studies have explored the neural 4 
correlates of this domain in clinical categories involving prodromal stages with different risk 5 
levels of conversion to AD. We assessed underlying electrophysiological modulations in patients 6 
with mild cognitive impairment (MCI), patients in the MCI stages of familial AD carrying the 7 
mutation E280A of the presenilin-1 gene (MCI-FAD), and healthy controls. Moreover, we 8 
compared the behavioral performance and neural correlates of both patient groups. Participants 9 
completed a change-detection VSTM task assessing recognition of changes between shapes or 10 
shape-color bindings, presented in two consecutive arrays (i.e., study and test) while event 11 
related potentials (ERPs) were recorded. Changes always occurred in the test array and consisted 12 
of new features replacing studied features (shape only) or features swapping across items (shape-13 
color binding). Both MCI and MCI-FAD patients performed worse than controls in the shape-14 
color binding condition. Early electrophysiological activity (100-250 ms) was significantly 15 
reduced in both clinical groups, particularly over fronto-central and parieto-occipital regions. 16 
However, shape-color binding performance and their reduced neural correlates were similar 17 
between MCI and MCI-FAD. Our results support the validity of the VSTM binding test and their 18 
neural correlates in the early detection of AD and highlight the importance of studies comparing 19 
samples at different risk for AD conversion. The combined analysis of behavioral and ERP data 20 
gleaned with the VSTM binding task can offer a valuable memory biomarker for AD. 21 
Keywords: Mild cognitive impairment, familial AlzheimerÕs disease, short-term memory, 22 
memory binding, EEG, ERPs. 23 
 5 
1. Introduction 1 
The temporary and integrated retention of perceptual features relevant to an object (e.g., shapes 2 
and colors) relies on short-term memory binding [1]. A subdomain of this function, called visual 3 
short-term memory (VSTM) binding, is impaired in patients with early-onset familial [2] and 4 
late-onset sporadic [3, 4] AlzheimerÕs disease (AD). Moreover, these deficits also emerge in 5 
asymptomatic and neuropsychologically normal carriers of the single mutation E280A in the 6 
presenilin-1 gene (E280A-PSEN1) [4], which leads to familial AD in 100% of cases [5]. Such 7 
difficulties are observed throughout an otherwise asymptomatic period, presumably starting 8 
around 12 years before disease onset [2]. Crucially, VSTM binding remains uncompromised 9 
throughout normal aging [6-8] and in other types of non-AD dementia [9]. 10 
 11 
Therefore, VSTM binding deficits seem to constitute an early and specific marker for AD [2-4], 12 
appearing in familial and sporadic variants long before other disturbances tapped by classical 13 
neuropsychological tasks. In this sense, further research is needed to assess whether the VSTM 14 
binding task can validly and reliably detect subtle deficits in patients at risk for AD, such as 15 
those with mild cognitive impairment (MCI) [10, 11]. To date, only one study has reported 16 
behavioral VSTM binding deficits in this population [12], and none has explored their 17 
underlying electrophysiological correlates. The latter gap needs to be bridged, especially since 18 
electrophysiological methods are robust, non-invasive, low-cost tools [13] to trace 19 
neurocognitive changes throughout both the asymptomatic and symptomatic stages of AD [14]. 20 
 21 
To this end, we explored whether VSTM binding impairments are associated with 22 
electrophysiological changes in two clinical groups at different risk levels for AD: patients who 23 
 6 
may develop late-onset sporadic AD such as those with MCI (most of them amnestic MCI, single 1 
or multi-domain) and patients in the prodromal stages of familial AD carrying the mutation 2 
E280A of the presenilin-1 gene (MCI-FAD). Specifically, we compared behavioral and event-3 
related potential (ERP) measures between these samples and healthy controls. Building on 4 
previous findings, we hypothesized that both patient samples would show behavioral and 5 
electrophysiological abnormalities in the VSTM task, particularly in the memory binding 6 
condition. Moreover, since the risk of conversion to AD is 100% for MCI-FAD and much lesser 7 
for MCI, we predicted different behavioral and electrophysiological profiles in each group. In 8 
particular, we expected that MCI-FAD would show more restricted behavioral and 9 
electrophysiological abnormalities in the binding relative to shape only condition of the VSTM 10 
task. More generally, this study seeks to test the sensitivity of this memory biomarker as a 11 
potential contribution to the early identification of AD pathology. 12 
 13 
2. Materials and methods 14 
 15 
2.1. Participants 16 
Thirteen patients with MCI were recruited from the Institute of Cognitive Neurology (INECO) in 17 
Buenos Aires, Argentina. Diagnosis was based on criteria by Pertersen [15] and Winblad et al. 18 
[16] (for further details, see Supplementary Data S1). All the patients underwent neurological, 19 
neuropsychiatric, and neuropsychological evaluations. Most of the patients (n = 9) were impaired 20 
in memory functions (amnestic MCI single domain or amnestic MCI multi-domain) while three 21 
patients were classified as non-amnestic MCI multi-domain. Both amnestic MCI single and 22 
multi-domain patients were included since these two clinical phenotypes have been shown high 23 
 7 
risk for AD conversion [17].  1 
 2 
The MCI-FAD sample comprised 10 patients recruited from the Colombian province of 3 
Antioquia. All of them carried the mutation E280A of the presenilin-1 gene, which leads to 4 
early-onset familial AlzheimerÕs disease in 100% of carriers [5]. These patients also completed 5 
formal neurological and neuropsychological assessments.  6 
 7 
Two separate groups of healthy participants were formed as controls for the MCI and MCI-FAD 8 
groups. These samples, which comprised 14 and 10 individuals, respectively, were matched for 9 
age and education with their respective patient samples and recruited from their corresponding 10 
geographical area. For further details about the control groups, see Tables 1 and 2, as well as 11 
Supplementary Data S1.  12 
 13 
Neither the patients nor the controls had a history of psychiatric or neurological diseases. All 14 
participants provided written informed consent in agreement with the Helsinki declaration. The 15 
Ethics Committees of the University of Antioquia and INECO approved this study. 16 
 17 
2.2. Neuropsychological assessment 18 
The general cognitive status of MCI patients was assessed with the mini mental state 19 
examination (MMSE) [18] and the AddenbrookeÕs cognitive examinationÐrevised (ACE-R) [19]. 20 
Their premorbid intellectual level was examined with the word accentuation test [20]. Memory 21 
was assessed with the Rey auditory verbal learning test (RAVLT) [21] and the recall of the 22 
complex Rey figure [21]. Attention and executive functions were evaluated via a digit span task 23 
 8 
[22], the two parts of the trail-Making test (TMT-A and TMT-B) [21], and a verbal fluency task 1 
[21, 23]. Visuospatial and constructional abilities were assessed with the copy task of the 2 
complex Rey figure [21]. Additional data were garnered through the instrumental activities of 3 
daily living scale (IADL) [24] and the geriatric depression scale (GDS) [25].  4 
 5 
MCI-FAD patients were evaluated with the MMSE, the verbal fluency task, the TMT-A, the 6 
copy and recall task of the complex Rey figure, and the IADL. Demographic and 7 
neuropsychological data of these patients were compared to those of the control group or to the 8 
local norms [26, 27] via independent sample and one sample t-tests, respectively.  9 
 10 
2.3. The visual short-term memory task 11 
The VSTM task taps change-detection skills to assess memory for single or combined features 12 
[4]. It is sensitive to impairments of integrative memory functions in both late-onset sporadic and 13 
familial AlzheimerÕs disease [2-4, 28]. The task consists of visual arrays of stimuli sequentially 14 
presented on a computer screen. An example of a trial is shown in Figure 1. Each trial features a 15 
study array followed by a test array. In 50% of the trials, the two arrays show identical items. In 16 
the remaining half, two items in the test array are replaced by new items. The to-be-remembered 17 
items change location from study to test, rendering location an uninformative feature (i.e., it 18 
cannot be used as a memory cue). Participants are asked to remember the items shown during the 19 
study and decide whether the items that follow in the test display are the same or different (see 20 
more details in Supplementary Data S2).  21 
 22 
The stimuli consisted of either single shapes (i.e., VSTM for single features) or shapes combined 23 
 9 
with colors (i.e., VSTM binding). Each type of stimulus was presented in a separate condition. 1 
During the shape-only condition, participants viewed three black shapes for study. In the test 2 
array for Òdifferent trialsÓ, two of the previously studied items were replaced by new shapes. In 3 
the shape-color binding condition, participants were presented with three shapes, each in a 4 
different color. Detection of changes across displays now required remembering the 5 
combinations of shape and color presented in the study array. In the test display for Òdifferent 6 
trialsÓ, the color of two shapes swapped relative to the ones they had in the study phase. No 7 
shape or color was repeated within a given array. Previous research has shown that healthy 8 
memory for binding is consistently defined by memory for the more challenging feature [29-31]. 9 
It is therefore revealing when this relationship between memory for binding and memory shapes 10 
is lost in AD. However, color has not showed to constrain consistently memory for binding as 11 
shape did it. Thus, the shape-binding comparison presents a conservative and reliable indicator 12 
of an impairment that is unrelated to task difficulty [30].  13 
 14 
Each condition consisted of a brief practice session followed by 100 test trials per experimental 15 
condition (200 trials in total). Trials were fully randomized across participants and conditions 16 
were delivered in a counterbalanced order. 17 
 18 
2.4. EEG recording 19 
MCI patients and controls 20 
MCI patients and their controls sat comfortably at a desk with a computer, set up in an 21 
electrically shielded, dimly lit room. As they performed the VSTM task, EEG recordings were 22 
obtained with a Biosemi 128-channel Active Two system (Amsterdam, NLD). The sampling rate 23 
was set at 512 Hz, and signals were bandpass filtered between 1 Hz (high pass) and 100 Hz (low 24 
 10 
pass). 1 
 2 
MCI-FAD patients and controls 3 
MCI-FAD patients and their controls completed the task in a room offering similar conditions as 4 
the one described above. EEG activity was collected using 64-channel SynAmps 2.5 system 5 
from Neuroscan. In order to eliminate oculomotor artifacts, the EOG signal was collected with 4 6 
electrodes (HEOR, HEOL, VEOL, and VEOU). Impedances were kept below 10 KΩ. The 7 
sampling rate was set at 500 Hz, and signals were bandpass filtered between 1 Hz (high pass) 8 
and 100 Hz (low pass). 9 
 10 
2.5. Data analyses 11 
Behavioral data 12 
Comparisons of demographic and neuropsychological data between each patient sample and its 13 
corresponding control group were performed via parametric t-tests. As in previous studies [2, 12], 14 
corrected recognition in the VSTM task was calculated by subtracting the proportion of false 15 
alarms from the hits. We followed the same procedure for each sample (MCI vs. controls and 16 
MCI-FAD vs. controls) and condition (shape only and shape-color binding) Ð see Supplementary 17 
Data S4. These indexes were compared through non-parametric Mann-Whitney U tests with 18 
Bonferroni correction. 19 
 20 
Considering that MCI and MCI-FAD groups were different in terms of age, for this calculation 21 
we used control-group-derived parameters of the variables revealing significant between-group 22 
differences (i.e., patients vs. their respective controls). For each MCI and MCI-FAD patient, we 23 
 11 
calculated normalized z scores using parameters (mean and SD) derived of the respective control 1 
group. Z-scores were then compared across the two groups through a non-parametric Mann-2 
Whitney U test. In addition, the effect size for all pairwise comparisons was calculated following 3 
the CohenÕs method. 4 
 5 
ERPs 6 
MCI and MCI-FAD data were analyzed offline following the same procedures. Analyses were 7 
performed with EEGLAB (version 13.1.1b) and MATLAB (version R2012a). Data were filtered 8 
between 0.5 Hz (high-pass) and 30 Hz (low-pass) and were down-sampled to 256 Hz. EEG 9 
activity was re-referenced to the grand average. Visual inspection of the data was followed by 10 
independent component analysis (ICA) to further remove oculomotor artifacts. Continuous EEG 11 
data were segmented in epochs of -200 to 1000 ms locked to stimulus onset. Epochs containing 12 
artifacts which exceeded a threshold of +/− 100 µV were manually removed. Separate average 13 
waveforms were computed for each individual in each condition of the VSTM task (i.e., shape 14 
only and shape-color binding). Only correct trials were considered for analysis.  15 
 16 
First, to identify significant between-group differences across the two conditions, we used a 17 
combination of the Monte Carlo test and non-parametric bootstrapping running 4.000 18 
permutations. The data were later analyzed by applying 4.000 permutation draws to generate a 19 
histogram called the Monte-Carlo approximation of the permutation distribution. To calculate the 20 
differences between our data and this distribution, we used the Monte-Carlo estimation of the 21 
permutation p-value, which is the proportion of random partitions in which the observed test 22 
statistic is larger than the value drawn from the permutation distribution. If this p-value is smaller 23 
 12 
than the critical alpha-level, then it is concluded that the data between the two groups are 1 
significantly different. This method offers a straightforward solution for multiple comparison 2 
problems and does not depend on multiple comparisons correction or Gaussian assumptions 3 
about the probability distribution of the data [33, 34]. This approach has been used in recent 4 
ERPs reports of our group [35-37]. Permutations were calculated following a component-free 5 
approach across the entire array of electrodes for every millisecond. Electrodes with significant 6 
results (p < .01) were placed into regions of interest (ROIs), and the activity within such regions 7 
was averaged out. We considered six ROIs: (1) fronto-central left (FC left), (2) fronto-central 8 
right (FC right), (3) centro-parietal left (CP left), (4) centro-parietal right (CP right), (5) parieto-9 
occipital left (PO left), and (6) parieto-occipital right (PO right). For each ROI we assigned 10 
seven and fourteen electrodes in the MCI and MCI-FAD samples respectively (see 11 
Supplementary Figure 1).  12 
 13 
Then, we compared the average activity from the six ROIs using 4.000 bootstrapping 14 
permutations (p < .05). Such contrasts were independently carried out in three time-windows 15 
(early: 100-250 ms; intermediate: 250-500 ms; late: 500-900 ms) for each condition (shape only 16 
and shape-color binding), memory phase (encoding and test), and group Ð see Supplementary 17 
Data S4. This activity was also compared across groups: (a) MCI vs. controls, (b) MCI-FAD vs. 18 
controls, and (c) MCI vs. MCI-FAD. These analyses were focused on four different components: 19 
N1, P2, P3, and LPP. The N1 is a parieto-occipital negative component [38], peaking around 170 20 
ms post-stimulus onset, which reflects early stages of visual processing and is sensitive to 21 
different types of attention [39, 40]. The P2 is a positive component with fronto-central 22 
distribution, peaking around 150-300 ms [41]. This component has been associated with 23 
 13 
attentional control processes, such as stimulus evaluation [41] and feature detection of task-1 
relevant stimuli [42]. The P3 is a positive centro-parietal component, which peaks between 300 2 
and 600 ms post-stimulus-onset, and is considered to reflect activity in a distributed network 3 
associated with attention and working memory [43, 44], including context updating and 4 
attentional resource allocation [45]. The LPP is a slow positive modulation with an onset around 5 
400-1000 ms after stimulus presentation. The enhancement of this component has been related to 6 
memory encoding and storage processes [46, 47]. Moreover, it has been associated with post-7 
retrieval stages, such as decisional monitoring [48] and evaluation [49-52] processes. All the 8 
functions indexed by these components are called upon by the VSTM task. 9 
 10 
3. Results 11 
3.1. MCI patients vs. healthy controls 12 
Behavioral data 13 
Neuropsychological assessment 14 
The results of the neuropsychological assessment are shown in Table 1. Relative to controls, 15 
MCI patients had poorer cognitive performance on both screening tests and on the majority of 16 
standard neuropsychological measures (memory, language, and attention) Ðsee details in S4. 17 
 18 
VSTM task 19 
There were no significant within-group differences in response accuracy between task conditions 20 
in controls (Mann-Whitney U: 66.5, Z = 1.42, p = .16, d = .60) or MCI patients (Mann-Whitney 21 
U: 54, Z = 1.54, p = .12, d = 0.64). MCI patients performed significantly worse than controls in 22 
both the shape-only (Mann-Whitney U: 42.5, Z = 2.33, p < .05, d = .91) and the shape-color 23 
 14 
binding (Mann-Whitney U: 42.0, Z = 2.35, p < .05, d = .92) conditions (see Figure 2D). 1 
 2 
ERP results 3 
MCI vs. controls 4 
Shape-only condition. Significant differences in P2 amplitude during the encoding phase 5 
emerged during the early time-window (100-250 ms) over the bilateral FC region (left: t = 3.16, 6 
p < .01, d = 1.22; right: t = 3.16-, p < .01, d = 1.21). The same was true of the LPP amplitude 7 
during the late time-window (500-900 ms) over the right CP region (t = 2.20, p < .05, d = .84). 8 
In the test phase, we found differences in N1 amplitude during the early time-window (100-250 9 
ms) over the right PO region (t = -2.40, p < .05, d = -.92) (see Figure 2A-C). 10 
 11 
Shape-color binding condition. There were significant differences in the encoding phase during 12 
the early time-window (100-250 ms). These concerned the P2 component over the bilateral FC 13 
region (left: t = 2.37, p < .05, d = 0.91; right: t = 2.43, p < .05, d = .93) and the N1 component 14 
over the right PO region (t = -2.33, p < .05, d = -.90). In the test phase, significant differences in 15 
N1 amplitude emerged during the early time-window (100-250 ms) over the PO region 16 
bilaterally (left: t: -2.53, p < .01, d = -.97; right: t = -3.15, p = .01, d = -1.20), and in the LPP 17 
during the late time-window (500-900 ms) over the right FC (t = 2.57, p = .02, d = 1.00) and the 18 
CP (t = 2.69, p = .01, d = .05) regions (see Figure 2A-C).  19 
 20 
 21 
 22 
 23 
 15 
3.2. MCI-FAD patients vs. healthy controls 1 
Behavioral data 2 
Neuropsychological assessment 3 
Demographic data and general cognitive state results are shown in Table 2. Statistical 4 
comparisons revealed that MCI-FAD patients had poorer general cognitive abilities and memory 5 
performance than healthy controls. However, the IADL scale revealed that they were highly 6 
functional, confirming the pre-dementia stage of this sample. 7 
 8 
VSTM task 9 
Response accuracy to the two VSTM task conditions was similar in both controls (Mann-10 
Whitney U: 34, Z = 1.17, p = .24, d = .64) and MCI-FAD patients (Mann-Whitney U: 28, Z = 11 
1.63, p = .10, d = .77). Between-group comparisons revealed higher accuracy for controls in the 12 
shape-color binding condition (Mann-Whitney U: 22.5, Z = -2.08, p < .05, d = .93), but no 13 
differences were observed in the shape-only condition (Mann-Whitney U: 25.0, Z = -1. 89, p 14 
= .063, d = 1.02) Ðsee Figure 3D. 15 
 16 
ERPs results 17 
MCI-FAD vs. controls 18 
Shape-only condition. Significant differences during the encoding phase were observed for the 19 
P3 component in the intermediate time-window (250-500 ms) over the left PO region (t = -2.17, 20 
p < .05, d = .75) Ðsee Figure 3A-C.  21 
 22 
Shape-color binding condition. We found significant between-group differences in the amplitude 23 
 16 
of two components during the encoding phase: P2, over the right FC region (t = 2.57, p < .05, d 1 
= 1.08); and N1, over the left PO region (t = -2.91, p < .01, d = -1.14); both patterns emerged 2 
during the early time-window (100-250 ms) Ðsee Figure 3A-C. 3 
 4 
3.3. MCI vs. MCI-FAD 5 
VSTM task 6 
No significant differences emerged between groups upon comparing their Z-scores (see details in 7 
data analyses) from performance on the shape-color binding condition of the VSTM task (Mann-8 
Whitney U: 63, Z = -.09, p = .93, d = .02) Ðsee Supplementary Figure 4.  9 
 10 
ERPs results 11 
We also compared the patientsÕ Z-scores drawn from the electrophysiological data that indicated 12 
significant between-group differences over specific ROIs and time-windows. Only the ERP 13 
activity elicited during the shape-color binding condition met these criteria (FC right, during the 14 
encoding phase, in the early time-window). However, contrasts between MCI and MCI-FAD 15 
including this activity revealed no significant differences (see supplementary Figure 4).  16 
 17 
Summary of findings 18 
Behavioral performance on the shape-color binding condition was significantly worse in MCI 19 
and MCI-FAD than in their respective control groups. No differences between MCI and MCI-20 
FAD were observed in the shape-color binding condition. Also, comparisons between each 21 
patient group and its respective controls showed that performance on the shape-only condition 22 
was impaired for MCI but not for MCI-FAD patients. 23 
 17 
 1 
ERP activity underlying VSTM performance was significantly reduced in MCI and MCI-FAD 2 
patients compared to their corresponding control groups (Table 3). This was observed in all ROIs, 3 
with most conspicuous activation decreases appearing over FC and PO regions during the early 4 
time-window (N1 and P2). MCI patients exhibited reduced amplitude across both conditions and 5 
memory phases, whereas MCI-FAD patients showed reduced amplitude in both conditions but 6 
only during the encoding phase. Differences in behavioral performance were associated to 7 
measurable differences in the underlying ERPs in MCI patients. For MCI-FAD patients, 8 
differences observed in the ERPs elicited during the shape-only condition were not accompanied 9 
by significant differences in behavioral performance. However, such an association was present 10 
for the shape-color binding condition. Finally, analysis of electrophysiological data from MCI 11 
and MCI-FAD patients showed no differences in the shape-color binding condition between 12 
groups, although both exhibited significant deficits in this function. 13 
 14 
 4. Discussion 15 
To our knowledge, this is the first study comparing the behavioral and electrophysiological 16 
correlates of VSTM binding deficits in patients in the prodromal stages (i.e., MCI) of sporadic 17 
and familial AD. The two samples shared a common phenotype characterized by behavioral and 18 
electrophysiological deficits during the shape-color binding condition of the VSTM task. These 19 
results lend further support to the validity of the VSTM binding test in the early detection of 20 
dementia. By comparing a sample of MCI patients with 100% probability of conversion to AD 21 
with a sample of MCI patients with a less certain conversion probability, we have identified a 22 
VSTM binding deficits as marker common to both populations. Below we discuss the theoretical 23 
 18 
implications of our findings. 1 
 2 
4.1. Behavioral performance on the VSTM task 3 
MCI patients performed significantly worse than healthy controls in both the shape-only and 4 
shape-color binding conditions of the VSTM task. These findings are consistent with those 5 
reported in a recent study [12] using the same task. However, previous studies in patients with 6 
early-onset familial [2] and late-onset sporadic AD [3, 4] have found a selective deficit in the 7 
shape-color binding condition. The discrepancy across these studies may be due to 8 
methodological differences. Previous studies have equated performance on the baseline 9 
condition (i.e., shape only) across patients and controls by assessing the former with smaller set 10 
sizes (i.e., patients saw arrays of two items and controls saw arrays of three items). In the present 11 
study, as in the one conducted by [12], patients were assessed with the same set size. We 12 
followed the logic of earlier studies involving pre-symptomatic mutation carriers [2]. That is, 13 
patients who did not meet criteria for dementia and controls were evaluated under the same 14 
testing conditions (i.e., same memory load). Although this approach proved valid for the 15 
preclinical stages of AD, it does not seem to hold for the clinical stages (i.e., MCI). Nevertheless, 16 
shape-only is just a baseline condition which does not hold sensitivity and specificity for AD. It 17 
is the shape-color binding condition of the task that has proved clinically relevant. Future studies 18 
interested in the previously reported dissociation (i.e., shape-only vs. shape-color binding) may 19 
want consider this methodological caveat. In fact, our results show that impairments in shape-20 
color binding are systematically observed across the two populations and were the only deficits 21 
found in those with the highest risk for AD (MCI-FAD).  22 
 23 
 19 
MCI-FAD patients were outperformed by controls, but the difference only reached significance 1 
in the shape-color binding condition. This finding aligns with previous reports of VSTM binding 2 
deficits in asymptomatic carriers of the mutation E280A in the presenilin-1 gene [2, 3]. Although 3 
mutation carriers in the present study were in more advanced stages of the disease process, our 4 
results corroborate that VSTM binding deficits may emerge well before the onset of full-blown 5 
AD. Note that mean scores for the shape-only condition also evinced a drop in MCI-FAD 6 
patients. However, unlike what was observed in MCI, this difference did not reach significance. 7 
This discrepancy could partially reflect age differences between the samples, as MCI patients 8 
were older than MCI-FAD patients. Although age does not differentially affect short-term 9 
memory binding abilities [6, 8, 53], it has an overall impact on short-term memory. This may 10 
account for the slightly greater difference between conditions in each group. However, 11 
performance on the shape-color binding condition was similar between patient groups. 12 
Accordingly, VSTM binding seems to be selectively compromised by AD, above and beyond the 13 
effects of age. As suggested in previous research then, this memory function may well constitute 14 
a sensitive marker for AD [3, 4, 6, 9]. Note that although Argentinean controls were older and 15 
had more years of education than those from Colombia, the behavioral performance of these 16 
samples was indistinguishable Ðsee also Parra, et al. [3], who reported similar findings in 17 
samples of sporadic and familiar AD. Therefore, demographic variables could be ruled out as a 18 
factor behind the key findings reported here and in previous studies. 19 
 20 
4.2. Electrophysiological correlates of the VSTM task 21 
Compared to controls, MCI patients exhibited reduced amplitudes in all ERP components 22 
associated with the VSTM task. The cognitive mechanisms supporting this memory function 23 
 20 
seem to be attenuated along relevant processing stages. Specifically, the amplitude of the N1 1 
component was reduced in both memory phases of the shape-color binding condition, and in the 2 
test phase of the shape-only condition. Notably, the scalp distribution (and similar source space 3 
[38]) of the diminished N1 was detected over parieto-occipital regions. Enhancements of N1 4 
modulations have been associated to facilitatory mechanisms of spatial attention and orientation 5 
towards task-relevant stimuli [39, 40], which subserve discrimination processes [54]. Moreover, 6 
N1 modulations may be sensitive to variations in the visual parameters of stimulus configuration 7 
[55], reflecting early information processing prior activation of abstract feature representations of 8 
the perceived objects. Also, during the encoding phase of both task conditions, P2 modulations 9 
were less positive-going in MCI patients than in controls. These differences were observed over 10 
bilateral fronto-central regions, in line with the previously reported source of this component 11 
[41]. The P2 seems to index stimulus evaluation [41] and detection of features in task-relevant 12 
stimuli [42]. Thus, diminished amplitudes of the N1 and P2 components in MCI patients may 13 
reflect abnormalities in the early visual integration stages of memory binding. These findings 14 
suggest impairments in processing of stimulus features and detection of relevant features, 15 
mechanisms related to visual and orbitofrontal association cortices, respectively. 16 
 17 
These findings could be interpreted at the neural network level. Recent findings have shown a 18 
structural and functional default-model network disruption in AD, which is related to 19 
components of the disease pathology such as amyloid and tau deposition [56]. In the earliest 20 
stages of disease, functional disruption in default-mode network regions involves affectation of 21 
medial temporal lobe structures that are implicated in the declarative memory system. In line 22 
with this evidence, it has been proposed that neurofibrillary tangles develop initially in the 23 
 21 
anterior subhippocampal (perirhinal/entorhinal) cortex before the hippocampus [57]. The anterior 1 
subhippocampal area forms part of the anterior mesiotemporal network which has been 2 
associated with Òobject-based context-free memoryÓ [57]. These areas would receive perceptual 3 
and semantic [58] information to perform higher-level inter-items associations [59].  4 
 5 
MCI patients also exhibited reduced amplitudes in the LPP component. This occurred first over 6 
centro-parietal regions during the encoding phase of shape-only condition, which may reflect a 7 
general encoding deficit. Consistent with this interpretation, it has been suggested that LPP 8 
enhancement reflects additional involvement of memory encoding and storage processes [46, 47]. 9 
A more elaborate encoding is associated with larger LPP amplitude over parietal scalp sites [60, 10 
61]. Thus, relative to MCI patients, control subjects may have deployed more successful 11 
encoding strategies during perceptual input. 12 
 13 
Furthermore, reduced LPP amplitude was also observed in MCI patients during the test phase of 14 
shape-color binding over centro-parietal and fronto-central electrodes. This abnormal pattern 15 
may be related to better control mechanisms during retrieval and post-retrieval processes, 16 
reflecting differences in monitoring and evaluation processes required to decide whether a 17 
change across study and test arrays. In line with this view, the LPP has been implicated in post-18 
retrieval processes, such as decisional monitoring [48] and evaluation [49-52]. For instance, 19 
Eimer and Mazza [50] showed reduced LPP amplitudes when participants were uncertain about 20 
the presence of a change between stimulus displays. Thus, convergent evidence suggests that in 21 
MCI patients, impaired evaluation and monitoring processes during the comparison of the two 22 
memory arrays may increase uncertainty about feature changes, particularly in the shape-color 23 
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 22 
binding condition. From a behavioral perspective, this is consistent with the view that higher 1 
similarity between study- and test-item configurations induces greater error rates during the 2 
comparison stages of a change-detection task [62]. Comparison processes between arrays 3 
containing multi-feature objects seem to demand more cognitive resources than those required to 4 
compare single-feature objects. Such resources would avoid misattribution of features across 5 
objects, thus contributing to solve the binding problem. Our results indicate that a fronto-parietal 6 
network may subserve these binding operations, and that failures of such a network are crucially 7 
related to memory binding impairments in patients at risk for AD. 8 
 9 
It is worth mentioning that despite the vast existing literature regarding the deficit in associative 10 
memory resulting from damage to the hippocampus which has proved a significant predictor of 11 
likelihood of conversion from MCI to AD, the evidence regarding the VSTM task has 12 
consistently shown that memory binding functions assessed by this change detection paradigm 13 
does not involve the hippocampus [63-65]. Indeed, the change detection task reported here has 14 
proved to be performed accurately after hippocampal pathology [64]. Moreover, a recent fMRI 15 
study in healthy individuals [5] has been shown that binding function does not involve the 16 
hippocampus but it relies on a network that involves the activity of parietal and occipito-17 
temporal areas. 18 
 19 
Otherwise, LPP retrieval-related activity has been associated with processes of familiarity and 20 
recollection (dual process model of recognition) [66] both of which contribute to performance on 21 
change detection tasks. Consistent with our results, a recent ERP study [67] showed that 22 
amnestic MCI patients present an attenuation of LPP waveforms during the performance of a 23 
 23 
recognition memory task when they retrieved memories based on recollection and familiarity 1 
processes. Thus, this evidence suggests that in MCI patients, reduced amplitude of LPP in the 2 
shape-color binding condition may involve retrieval affectation of recollection and familiarity-3 
based memories, either because fewer items are retrieved, and/or fewer entire item-4 
configurations have been successful retrieved. 5 
 6 
In addition to visual electrophysiological markers found in our study, the P50 auditory 7 
component has been recently proposed as a candidate ERP biomarker of prodromal AD [68]. 8 
MCI patients with Amyloid and p-Tau positive showed larger P50 amplitudes relative to the 9 
amlyloid-negative patients during the performance of an oddball task, which reflects poorer 10 
inhibitory control to sensory information. However, despite the amplitude of P50 is larger in 11 
MCI relative to older normal controls, it increases with normal aging [69, 70]. Crucially, VSTM 12 
binding has been shown to be more specific since it remains uncompromised throughout normal 13 
aging [6, 71, 72]. Therefore, combining with ERP, the VSTM task may offer a unique 14 
opportunity to detect early neurocognitive abnormalities associated with risk for AD.  15 
 16 
MCI-FAD patients exhibited attenuated electrophysiological responses only in the encoding 17 
phase of the VSTM task. Specifically, they showed reduced amplitudes of N1 and P2 18 
components associated to shape-color binding processing over parieto-occipital and fronto-19 
central regions, respectively. As we discussed above, reduced N1 amplitude may reflect 20 
difficulties to direct attention to task-relevant stimuli [39, 40] and process attributes of visual 21 
configurations [55], all linked to early visual processing. Reduced amplitude of the P2 22 
component seems related to deficits in stimulus evaluation [41] and features detection processes 23 
 24 
[42]. Limitations to encode feature bindings in MCI may thus originate quite early in the visual 1 
processing stream. MCI-FAD patients also showed reduced amplitude of the P3 component over 2 
parieto-occipital regions in the shape-only condition. This component is considered to reflect 3 
activity in a distributed network subserving attention and working memory [43, 44], including 4 
context updating and resource allocation [45]. Specifically, P3 increases when stimulus encoding 5 
promotes successful memory storage and facilitates retrieval during recognition tasks [73]. Thus, 6 
while behaviorally unimpaired, MCI-FAD patients did show electrophysiological evidence of 7 
subthreshold anomalies during the shape-only condition of the VSTM task. These subthreshold 8 
impairments support the proposal that the mechanisms responsible for holding combinations of 9 
shape and color in VSTM are affected by AD to a far greater extent than those responsible for 10 
holding single features, such as shapes. Previous ERP studies assessing memory impairments in 11 
E280A-PSEN1 presymptomatic mutation carriers have reported functional disruption of brain 12 
regions similar to those reported in our study [74, 75]. Taken together, all these findings 13 
highlight the importance of ERP analysis to unveil key neural correlates of cognitive 14 
impairments throughout the continuum of AD.  15 
 16 
Finally, we compared electrophysiological data from MCI and MCI-FAD considering variables 17 
which indicated departure from normality. Specifically, we focused on P2 modulations during 18 
the encoding phase of the shape-color binding condition over the right fronto-central ROI. 19 
Crucially, no between-group differences were observed. This suggests that both prodromal 20 
stages of AD (i.e., sporadic-MCI and familiar-MCI) share a common behavioral and 21 
electrophysiological phenotype associated to VSTM binding. Such ERP abnormalities seem to 22 
reflect impairments during early sensory processing, which are probably associated with stimulus 23 
 25 
evaluation [41] and feature detection [42]. When we compared patients to their respective 1 
controls, both clinical samples showed decreased N1 activity over parieto-occipital regions, 2 
suggesting similar deficits in feature discrimination processes [54]. As recently shown in fMRI 3 
studies [29, 76-78], these regions seem to support spatial attentional mechanisms necessary to 4 
integrate features in VSTM. Therefore, the reduced amplitudes observed in MCI and MCI-FAD 5 
during the encoding of shape-color bindings over fronto-central and parieto-occipital regions 6 
could be associated to specific impairments in attentional mechanisms supporting feature 7 
conflation in VSTM. We argue that these indexes of activation could to reflect reduced 8 
attentional control efficiency in frontoparietal attention circuit required for 9 
encoding/consolidation binding in VSTM. In sum, the abnormalities observed during the 10 
encoding stages in both patient samples could account for behavioral feature-binding 11 
impairments in the VSTM task.  12 
 13 
Providing that age is not an influential factor, contrasting performance of MCI patients whose 14 
phenotype unequivocally suggests the presence of AD (younger MCI-FAD patients) with those 15 
with a less certain phenotype (older MCI patients), enables assessment of whether such VSTM 16 
binding deficit are a phenotypic feature of prodromal AD regardless of its clinical variant. In line 17 
with previous studies suggesting that is the case for patients with the full-blown disease [2], our 18 
results revealed that this also characterizes stages of AD prior to diagnosis. Although these 19 
results are appealing, they also pose some challenges as contrary to our MCI-FAD cases, we do 20 
not predict that 100% of our MCI cases will progress to AD. Future studies involving larger 21 
samples of MCI patients should investigate the specific phenotype of those patients who drive 22 
such a group effect reported here. 23 
 26 
 1 
Neurocognitive processes can be studied appropriately with high-temporal resolution techniques 2 
such as EEG. These methods are suited to capture properties of transient cognitive events [79] 3 
which may be undetected via high-spatial resolution techniques, such as fMRI. In the context of 4 
the VSTM binding task, previous fMRI studies [78] did not identify task-related activation over 5 
frontal regions. In the present study, within-group analyses showed significant enhanced fronto-6 
central activity during the test phase of the shape-color binding condition. However, we did 7 
corroborate the involvement of posterior (viz., parietal) regions in feature binding. Therefore, our 8 
results suggest that combining the VSTM task with ERP analysis may offer a unique opportunity 9 
to detect early neurocognitive alterations in individuals at risk for AD. Such electrophysiological 10 
findings underscore the potential of the VSTM task as a biomarker for AD. 11 
 12 
4.3. Implications and further assessments 13 
Electrophysiological markers could be considered in daily clinical practice to favor the early 14 
detection of AD. Such inexpensive, non-invasive measures are robust, fast to compute, and 15 
applicable for large-scale screening. This novel approach can overcome several limitations of 16 
available biomarkers for AD [14, 80]. As ERPs have high temporal resolution, they can detect 17 
subtle information-processing abnormalities, even in the absence of significant behavioral 18 
manifestations. Such methodological attributes have important clinical implications in the 19 
context of VSTM research. We have replicated behavioral VSTM binding impairments in AD 20 
samples [2, 9, 12], further demonstrating their presence in presymptomatic stages of AD (see 21 
also [1]). VSTM binding deficits thus seem to constitute a phenotypic feature of AD, detectable 22 
throughout the continuum of the disease. The task used in this study could represent a valuable 23 
 27 
tool to identify candidates for prevention trials. Previous ERPs studies [81-83] have proposed 1 
statistical methods for single-case analyses that can be implemented by future research assessing 2 
patients in prodromal stages of AD. Moreover, individual ERPs measures may be useful in 3 
follow-up clinical assessment of individuals at risk of developing AD or patients with diagnosis 4 
of MCI or AD. Longitudinal ERPs measures may provide further insights on the AD nature and 5 
may be potentially useful in predicting the disease progression based on the combination of 6 
behavioral and electrophysiological measures. Moreover, although computerized assessments of 7 
cognitive functions in the early detection of AD are not commonly used, their validity and 8 
reliability as testing tools for the clinical practice is being recognized [84]. Computerized testing 9 
tools have a number of complementary advantages. They allow more standardized, precise and 10 
objective measures of subject performance, and features such as randomization allow throw out 11 
practice effects. Finally, computerized assessment can be self-administered and may provide  12 
faster results. 13 
 14 
We acknowledge some limitations in the present work. First, the two patient samples are not 15 
comparable in terms of their demographic characteristics, and they were recruited from different 16 
countries. To control for these factors we standardized VSTM scores and demonstrated that, 17 
despite such differences, both samples shared a common phenotype both behaviorally and 18 
electrophysiologically. Finally, other important limitation is that our MCI group included 19 
different clinical phenotypes. However, our sample is similar to that reported in the only study 20 
that had assessed different clinical phenotypes of MCI with the VSTM task, in which most of 21 
patients were impaired in memory [85]. Future research may to study how sensitive VSTM 22 
binding is to cognitive and neuropathological changes considering larger MCI cohort with 23 
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different characteristics of clinical phenotypes.  1 
5. Conclusion 2 
The prodromal stages of AD are characterized by VSTM binding deficits cutting across sporadic 3 
and familial variants of the disease. Such deficits are accompanied by detectable and measurable 4 
electrophysiological abnormalities, which are also shared by MCI patients. The incorporation of 5 
ERP analyses can boost the sensitivity of the VSTM task to anticipate probable AD, both 6 
physiologically (by unveiling relevant biological mechanisms) and clinically (by detecting 7 
impaired individuals earlier). All in all, we advocate the combined analysis of behavioral and 8 
ERP data gleaned with the VSTM binding task can offer a valuable tool for assessing memory 9 
impairments in individuals at risk for AD. 10 
 11 
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Table 1. Demographic and neuropsychological data of MCI patients and controls, with 2 
results from statistical comparisons.  3 
 MCI (n = 13) controls (n = 14) t-test Effect size 
 Mean SD Mean SD t P CohenÕs d 
Age 73.08 9.01 67.21 10.14 -1.58 NS -0.61 
Education 14.08 4.44 16.50 1.99 1.85 NS 0.70 
GDS 6.00 3.74 4.93 2.95 -0.83 NS -0.32 
IADL (Fam) 6.38 1.06      
WAT 41.46 8.42 45.98 4.32 1.77 NS 0.67 
ACE-III 81.15 12.49 95.07 4.30 3.87 .0007 1.47 
MMSE 26.46 2.47 29.50 0.52 4.50 .0001 1.70 
RAVLT-Total Recall 28.77 9.49 43.93 9.22 4.214.13 .0003 1.62 
RAVLT-Delayed 
Recall 
4.46 3.71 11.09 10.06 2.24 .03 
0.87 
RAVLT-List 
Recognition 
(corrected) 
0.67 0.15 0.95 0.32 2.88 .008 1.12 
Rey Figure - Copy 30.42 4.58 32.16 5.80 0.86 NS 0.33 
Rey Figure - Recall 11.04 6.36 16.49 6.55 2.19 .04 0.84 
Rey Figure - 17.62 2.53 21.69 3.65 3.34 .003 1.29 
 40 
Recognition 
Digit Span 5.54 1.13 7.22 3.23 1.77 .09 0.69 
TMT-A 59.23 24.37 42.63 25.87 -1.71 NS -0.66 
TMT-B 183.38 119.47 87.81 46.52 -2.78 .01 -1.05 
Verbal Fluency F 12.08 5.20 17.50 9.30 1.85 NS 0.71 
Verbal Fluency A 11.54 4.41 21.74 22.41 1.61 NS 0.63 
Verbal Fluency S 11.23 3.17 15.14 2.91 3.35 .003 1.29 
NS: non-significant; RAVLT: Rey Auditory Verbal Learning Test; IADL: Instrumental 1 
Activities of Daily Living Scale; WAT: Word Accentuation Test; TMT-A: Trail-Making Test 2 
(part A); TMT-B: Trail-Making Test (part B); ACE: AddenbrookeÕs Cognitive Examination; 3 
MMSE: Mini-Mental State Examination. GDS: Geriatric Depression Scale.  4 
 5 
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 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 41 
 1 
Table 2. Demographic and neuropsychological data of MCI-FAD patients and healthy 2 
controls, with results from statistical comparisons. 3 
 
MCI-FAD 
(n = 10) 
Controls 
(n = 10) 
t-test Effect size 
 Mean SD Mean SD t p CohenÕs d 
Age 44.40 3.20 44.30 5.60 -0.05 NS -0.02 
Education 7.30 4.10 11.30 13.90 0.87 NS 0.38 
MMSE 25.20 4.50 29.10 1.10 2.75 .023 
0.86 
 
IADL (Fam) 7.2 1.0      
Verbal Fluency  15.3 5.0 21.4 4.8 3.66,  .006 1.02 
TMT-A 87.75 38.30 73.67 26.44 1.04 NS -0.33 
Rey Figure Ð Copy 21.89 5.03 26.38 4.99 2.68,  .028 0.73 
Rey Figure Ð Recall 7.33 4.89 14.32 5.18 4.29 .003 1.14 
NS: non-significant; IADL: Instrumental Activities of Daily Living Scale (IADL); MMSE: Mini-4 
Mental State Examination; TMT-A: Trail-Making Test (part A). 5 
 6 
 7 
 8 
 9 
 10 
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 1 
Table 3. Summary of significant results (p < .05) drawn from the ERP analyses. 2 
BETWEEN-GROUP CONTRASTS (PATIENTS VS. CONTROLS) 
100-250 
N1 
MCI vs. CTR TB TS EB TB     
FAD vs. CTR EB      
P2 
MCI vs. CTR     ES EB ES EB 
FAD vs. CTR      EB 
250-500  P3  
MCI vs. CTR       
FAD vs. CTR       
500-900  LPP 
MCI vs. CTR    ES TB  TB 
FAD vs. CTR       
 E=encoding, T=test, S=shape only, B=shape-color binding. 3 
 4 
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 3 
Figure 1. Examples of Òdifferent trialsÓ in each condition of the VSTM task.  4 
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Figure 2. (A) ERP activity from significant ROIs comparing MCI patients and controls in the 3 
shape-only (encoding and test) and shape-color binding (encoding and test) conditions. (B) 4 
Electrodes by numbers comprising the ROIs. Red points indicate significant electrodes. (C) 5 
Scalp distribution of activity during the early (100-250 ms) and late (500-900 ms) time-windows 6 
across conditions and groups. (D) Mean performance during the VSTM task in the shape-only 7 
and shape-color binding conditions. Error bars represent standard deviations from the mean. 8 
 45 
 1 
Figure 3. (A) ERP activity from significant ROIs comparing MCI-FAD and controls in the 2 
shape-only (encoding) and shape-color binding (encoding) conditions. (B) Electrodes by 3 
numbers comprising the ROIs. Red points indicate significant electrodes. (C) Scalp distribution 4 
of activity during the early (100-250 ms) and intermediate (250-500 ms) time-windows across 5 
conditions and groups. (D) Mean performance during the VSTM task in the shape-only and 6 
shape-color binding conditions. Error bars represent standard deviations from the mean. 7 
 8 
 9 
 10 
 11 
 12 
 13 
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Supplementary data 1 
S1. Participants 2 
Mild cognitive impairment patients 3 
MCI patients were diagnosed according to the criteria proposed by Pertersen [1] and Winblad et 4 
al. [2], namely: (1) change in cognition recognized by the affected individual and/or a close 5 
informant; (2) relatively preserved general cognition for age; (3) objective memory impairment 6 
(defined by scores of 1.5 SDs below age norms); (4) independence in functional activities; and (5) 7 
absence of dementia [3]. 8 
 9 
MCI subtypes 10 
Clinical phenotypes of MCI were distinguished based on previously established criteria [2, 4]. 11 
MCI patients were classified into three sub-groups according to an impairment threshold set at 12 
1.5 SDs for memory, executive functions, and attention capacity: non-amnestic MCI (in which 13 
patients had executive and/or attention impairments), amnestic MCI (in which patients had only 14 
memory impairment), and multi-domain MCI (in which patients had memory and executive 15 
and/or attention impairments). 16 
 17 
MCI-FAD patients 18 
MCI-FAD patients were recruited in a large kindred from the Colombian province of Antioquia. 19 
These individuals carried a gene mutation (i.e., E280A in the PSEN-1 gene) that leads to early-20 
onset familial AlzheimerÕs disease in 100% of cases [5]. At the time of assessment, all the 21 
participants led an active working life, proved functionally independent, and were off medication 22 
(i.e., anticholinesterase inhibitors). Patients with MCI-FAD met the definition proposed by [6]. 23 
 47 
All the participants had previously undergone genetic screening and the presence of the mutation, 1 
which was unknown both to the participants and the researchers, had been either confirmed or 2 
ruled out. 3 
 4 
S2. Visual short-term memory task 5 
The trial sequence was as follows: each trial began with a fixation cross visible for 500 ms. This 6 
was followed by the study array, which also remained on screen for 500 ms. Then came a blank 7 
retention interval of 900 ms, after which the test array appeared and persisted until the participant 8 
responded. Participants tested in Argentina used a mouse to indicate recognition of a change (or 9 
absence thereof) between the study and the test arrays (left button for Òsame trialÓ and right 10 
button for Òdifferent trialÓ). Participants tested in Colombia responded orally upon the 11 
experimenterÕs request. This procedure allowed the isolation of the artifact induced by verbal 12 
responses. The experimenter then entered participantsÕ responses using the keyboard. The results 13 
presented here suggest that these different procedures do not affect response accuracy. The two 14 
patient samples were affected and their impairments were indistinguishable. 15 
 16 
S3. Data analysis 17 
Behavioral data 18 
Neuropsychological assessment 19 
Comparisons among MCI subtypes 20 
Intra-group analyses within the MCI sample were performed to determine whether these 21 
subgroups are comparable in term of demographic (i.e. age, education) and cognitive functioning 22 
(ACE III).  This analysis was effectuated using a non-parametric Kruskal-Wallis test. A Tukey 23 
 48 
correction was applied to each comparison among MCI subtypes. 1 
 2 
VSTM task 3 
Comparisons among MCI subtypes 4 
For an intra-group analyses within the MCI sample, patients were pooled into three clinical 5 
phenotypes [1, 2, 4]: (a) non-amnestic MCI with deficits in a single domain (nMCI), (b) pure 6 
amnestic MCI (aMCI), and (c) multiple-domain amnestic MCI (mMCI) Ðsee S1. To compare the 7 
performance of these subgroups on the VSTM task, we used a non-parametric Kruskal-Wallis 8 
test. A Tukey correction was applied to each comparison among MCI subtypes. This procedure 9 
was not applied to the FAD-MCI patients as they were all in an mMCI stage. 10 
 11 
Comparisons between MCI and MCI-FAD 12 
As a confirmatory analysis in order to compare behavioral and ERP data between the MCI and 13 
FAD-MCI groups, we converted raw scores to z-scores. For this calculation we used group-14 
derived parameters (common mean and SD of the overall group) of the variables revealing 15 
significant between-group differences. Z-scores were then compared across the two groups 16 
through a non-parametric Mann-Whitney U test. In addition, for all pairwise comparisons the 17 
effect size CohenÕs method was calculated. 18 
 19 
 20 
 21 
 22 
 23 
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S4. Results  1 
S4.1 MCI patients vs. healthy controls  2 
Behavioral data 3 
Neuropsychological assessment 4 
Statistical comparisons revealed that MCI patients had poorer cognitive performance on both 5 
screening tests and on the majority of standard neuropsychological tests. The domains yielding 6 
more severe impairments were memory, language, and attention. However, no differences were 7 
found between MCI patients and controls in premorbid intelligence, copy of the Rey figure, 8 
TMT-A, digit span, and two of the phonological fluency task trials. Finally, MCI patients 9 
showed no impairments in daily living functions, which ruled out the presence of dementia (see 10 
Table 1 in main text). 11 
 12 
Comparisons among MCI subtypes 13 
MCI subgroups were comparable in terms of age (Kruskal-Wallis test H: 0.07, p = .96), years of 14 
education (Kruskal-Wallis test H: 1.34, p = .51) and in cognitive functioning (Kruskal-Wallis 15 
test H: 6.22, p = .08). 16 
 17 
There were significant differences among MCI subtypes in both the shape-only (Kruskal-Wallis 18 
test H: 8.6, p = .01) and the shape-color binding (Kruskal-Wallis test H: 6.5 p = .04) conditions. 19 
Multiple comparisons showed that nMCI outperformed mMCI on both the shape-only (Z = 2.54, 20 
p = .03, d = 2.50) and the shape-color binding (Z = 2.40; p = .05, d = 2.54) conditions. In 21 
addition, performance in the shape-only condition was better for aMCI than mMCI (Z = 2.44, p 22 
= .04, d = 2.52). No significant differences were found between aMCI and nMCI in any 23 
 50 
condition (see Supplementary Table 1). 1 
 2 
ERP results 3 
MCI patients 4 
Encoding phase. There were differences between conditions in the right FC region, departing 5 
from the P2 (t = -3.04, p < .01, d = -0.58) to the P3 component (t = -2.80, p < .05, d = -0.67), 6 
which emerged in the early time-window (100-250 ms) and extended over the intermediate time-7 
window (250-500 ms). Differences were also observed in the amplitude of the P2 component 8 
during the early time-window (100-250 ms) over the left (t = -2.30, p < .05, d = -0.37) and the 9 
right (t = -2.41, p < .05, d = -0.45) CP regions. Furthermore, there were differences over the right 10 
CP region in the P3 (t = -2.26, p < .05, d = -0.48) during the intermediate time-window (250-500 11 
ms) and in the LPP (t = -2.80, p < .01, d = -0.47) in a latency range of 500-900 ms. We also 12 
found bilateral differences over the PO region in the N1 (left: t = -2.35, p < .05, d = -0.36; right: t 13 
=  -2.98, p < .01, d = -0.42) and the LPP (left: t = -2.27, p < .05, d = -0.45; right: t = -2.82, p 14 
< .01, d = -0.59) components, in early (100-250 ms) and late (500-900 ms) time-windows, 15 
respectively.  16 
 17 
Test phase. We found differences in P2 amplitudes over bilateral FC regions (left: t = -2.48, p 18 
< .05, d = -0.57; right: t = 2.46, p < .05, d = 0.47) in the early time-window (100-250 ms). 19 
Significant differences also emerged in the N1 component over the left CP (t = -2.66, p < .05, d = 20 
-0.44) and bilateral PO regions (left: t = -3.55, p < .01, d = -0.40; right: t = -2.59, p < .05, d = -21 
0.48), both in early time-windows (100-250 ms) (see Supplementary Figure 2).  22 
 23 
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Closer inspection of the waveforms revealed that the above effects were driven by larger 1 
amplitudes of all the ERP components, except N1 and P2, during the shape-color binding 2 
condition relative to the shape-only condition. The amplitude of N1 during the encoding and test 3 
and the amplitude of P2 during the test phase were larger in the shape-only than in the shape-4 
color binding condition (see Supplementary Table 3).  5 
 6 
Controls 7 
Encoding phase. No significant differences between conditions were observed.  8 
Test phase. We found differences between conditions over the left FC region in the amplitude of 9 
the P2 (t = -2.53, p < .05, d = -0.65), P3 (t = -3.36, p < .05, d = -0.70), and LPP (t = -3.02, p < .05, 10 
d = -0.77) components during the early (100-250 ms), intermediate (250-500 ms), and late (500-11 
900 ms) time-windows, respectively. Differences in these time-windows were also observed in 12 
the left (early: t = -2.42, p < .05, d = -0.47; intermediate: t = -3.36, p < .01, d = -0.64; late: t = -13 
4.24, p < .01, d = -0.98) and right (early: t = -2.08, p < .05, d = -0.42; intermediate: t = -3.52, p 14 
< .01, d = -0.46; late: t = -3.87, p < .01, d = -0.78) CP regions for the P2, P3, and LPP 15 
components. In addition, there were differences over the right PO region, departing from the P3 16 
(t = -1.97, p < .05, d = -0.29) to the LPP (t = -3.45, p < .01, d = -0.53), which emerged in the 17 
intermediate time-window (250-500 ms) and extended over the late time-window (500-900 ms). 18 
Differences were also observed in the LPP component (t = -2.67, p < .05, d = -0.56) over the left 19 
PO during the late time-window (500-900 ms) (see Supplementary Figure 2). 20 
 21 
Closer inspection of the waveforms revealed that these effects were driven by larger amplitudes 22 
of all the ERP components in the shape-color binding condition compared to the shape-only 23 
 52 
condition (see Supplementary Table 3). 1 
 2 
S.4.2 MCI-FAD patients vs. healthy controls 3 
ERP results 4 
MCI-FAD patients 5 
Encoding phase. There were significant differences between conditions in the P2 amplitude over 6 
the left FC (t = -2.18, p < .01, d = -1.10) during the early time-window (100-250 ms). This time-7 
window also yielded differences in the N1 component over the right CP (t = 3.24, p < .05, d = 8 
1.26) and PO (t = 3.05, p < .05, d = 1.13) regions (see supplementary Figure 3). 9 
 10 
Test phase. There were differences between conditions in the N1 amplitude over the right PO 11 
region (t = 3.15, p < .05, d = 0.33) during the early time-window (100-250 ms) Ðsee 12 
supplementary Figure 3. 13 
These within-group analyses showed that all the ERPs exhibited greater amplitude in the shape-14 
color binding than in the shape-only condition (see Supplementary Table 3). 15 
 16 
Controls 17 
Encoding phase. We found significant differences between conditions over the left PO region in 18 
the amplitude of the N1 (t = 2.60, p < .05, d = 0.49) and P3 (t = 2.19, p < .05, d = 0.51) 19 
components during early (100-250 ms) and intermediate (250-500 ms) time-windows, 20 
respectively. There were also differences in the amplitude of the N1 (t = 3.00, p < .05, d = 0.32) 21 
over the right PO during the early time-window (100-250 ms) Ðsee supplementary Figure 3.  22 
 23 
 53 
Test phase. We found significant differences between conditions in the P2 component during the 1 
early window (100-250 ms) over the left FC (t = -3.08, p < .01, d = -0.95). Amplitude differences 2 
during that same time-window also emerged for the N1 component over the right CP (t = 2.97, p 3 
< .01, d = 0.81) and PO (t = 4.35, p < .01, d = 0.53) regions (see supplementary Figure 3). 4 
 5 
Closer inspection of the waveforms revealed that the above effects were driven by larger 6 
amplitudes of all the ERP components in the shape-color binding condition relative to the shape-7 
only condition (see Supplementary Table 3). 8 
 9 
S.4.3 MCI vs. MCI-FAD 10 
VSTM task 11 
No significant differences emerged between groups upon comparing their z-scores (see details in 12 
data analyses) from performance on the shape-color binding condition of the VSTM task (Mann-13 
Whitney U: 52.0, Z = .78, p = .44, d = .52).  14 
 15 
ERP results 16 
We also compared the patientsÕ z-scores drawn from the electrophysiological data which 17 
indicated significant between-group differences over specific ROIs and time-windows (see 18 
section 3.3 in the main text). However, contrasts between MCI and MCI-FAD including ERP 19 
activity revealed no significant differences (Mann-Whitney U: 63.0, Z = .09, p = .93, d = .05).  20 
 21 
 22 
 23 
 54 
Supplementary Table 1. VSTM task performance in different MCIÕs subgroups. 1 
 2 
VSTM task conditions Mean (SD) corrected recognition scores  
 nMCI (n = 4) aMCI (n = 4) mMCI (n = 5) Controls 
Shape only 0.50 (0.17) 0.47 (0.14) 0.05 (0.19) 0.45 (0.13) 
Shape-color binding 0.34 (0.15) 0.25 (0.24) -0.08 (0.18) 0.33 (0.22) 
 3 
 4 
 55 
Supplementary Table 2. Demographic data and general cognitive impairment in different 1 
MCIÕs subgroups. 2 
 Mean (SD)  
nMCI (n = 4) aMCI (n = 4) mMCI (n = 5) 
Age 73.00 (12.57) 71.50 (11.39) 74.40 (4.83) 
Education 14.25 (6.18) 15.75 (0.96) 12.60 (4.93) 
ACE III 87.25 (5.50) 88.25 (2.36) 70.60 (14.64) 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
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Table 3. Summary of significant results (p < .05) drawn from the ERP analyses. 1 
WITHIN-GROUP CONTRASTS (SHAPE ONLY VS. SHAPE-COLOR BINDING) 
 
Parieto-occipital 
Centro-
parietal Fronto-central 
Time-
windo
w (ms) 
ERP 
Group-
contrast 
L R L R L R 
100-
250 
N1 
MCI E T E T T     
MCI-CTR   T T   
FAD  E T   E     
FAD-CTR E E T  T   
P2 
MCI     E E T E T 
MCI-CTR     T  
FAD           
FAD-CTR     T  
250-
500  
P3  
MCI     E  E 
MCI-CTR  T T T T  
FAD            
FAD-CTR E      
500-
900  
LPP 
MCI E E  E   
MCI-CTR  T T T T  
FAD             
FAD-CTR       
 E=encoding, T=test, S=shape only, B=shape-color binding. 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
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Supplementary figures 1 
 2 
 3 
 4 
Figure 1. (A) ERP activity from significant ROIs between the shape-only and shape-color 5 
binding conditions in each memory phase of the VSTM task, in controls and MCI patients. (B) 6 
Electrodes by numbers comprising the ROIs.  7 
 8 
 9 
 10 
 11 
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 1 
Figure 2. (A) ERP activity from ROIs yielding significant differences between the shape-only 2 
and the shape-color binding conditions in each memory phase of the VSTM task, in controls and 3 
MCI-FAD patients. (B) Electrodes by numbers comprising the ROIs. 4 
 5 
 6 
 59 
 1 
Figure 3. Behavioral and electrophysiological comparisons between MCI and MCI-FAD during 2 
the VSTM task. The y-axis shows the means of the distance between patients and controls, as 3 
measured with z-values. Error bars represent standard deviations from the mean. The mean z 4 
value of behavioral performance in the shape-color binding condition is depicted on the left side. 5 
The mean z value of electrophysiological activity in the shape-color binding condition is 6 
portrayed on the right (ROI: FC right; memory-phase: encoding; time-window: 100-250 ms). 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
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 1 
  Figure 4. Implemented electrode dispositions by number in Colombia (MCI and controls, left 2 
panel) and Argentina (MCI-FAD and controls, right panel). 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
12 
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